CORDANI NICOLETTA
Ruolo:
Assegnista di ricerca
Settore scientifico disciplinare:
ONCOLOGIA MEDICA (MED/06)
E-mail:
Pubblicazioni
- Sharma, G., Cortinovis, D., Agustoni, F., Arosio, G., Villa, M., Cordani, N., et al. (2019). A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib. JOURNAL OF THORACIC ONCOLOGY, 14(11), e257-e259. Dettaglio
- Redaelli, S., Ceccon, M., Zappa, M., Sharma, G., Mastini, C., Mauri, M., et al. (2018). Lorlatinib Treatment Elicits Multiple On- and Off-Target Mechanisms of Resistance in ALK-Driven Cancer. CANCER RESEARCH, 78(24), 6866-6880. Dettaglio
- Piazza, R., Ramazzotti, D., Spinelli, R., Pirola, A., De Sano, L., Ferrari, P., et al. (2017). Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes. SCIENTIFIC REPORTS, 7. Dettaglio
- Piazza, R., Ramazzotti, D., Spinelli, R., Pirola, A., De Sano, L., Ferrari, P., et al. (2017). OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes. SCIENTIFIC REPORTS, 7. Dettaglio
- Gambacorti Passerini, C., Aroldi, A., Cordani, N., & Piazza, R. (2016). Chronic myeloid leukemia: Second-line drugs of choice. AMERICAN JOURNAL OF HEMATOLOGY, 91(1), 67-75. Dettaglio